Literature DB >> 20829424

Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.

Francis Verbeke1, Wim Van Biesen, Eero Honkanen, Björn Wikström, Per Bruno Jensen, Jean-Marie Krzesinski, Merete Rasmussen, Raymond Vanholder, Pieter L Rensma.   

Abstract

BACKGROUND AND OBJECTIVES: Radiographic calcification and arterial stiffness each individually are predictive of outcome in dialysis patients. However, it is unknown whether combined assessment of these intermediate endpoints also provides additional predictive value. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Scoring of abdominal aortic calcification (AAC) using plain lateral abdominal x-ray and measurement of carotid-femoral pulse wave velocity (PWV) were performed in a cohort of 1084 prevalent dialysis patients recruited from 47 European dialysis centers.
RESULTS: During a follow-up of 2 years, 234 deaths and 91 nonfatal cardiovascular (CV) events occurred. Compared with the lowest tertile of AAC, the risk of an event was increased by a factor 3.7 in patients with a score of 5 to 15 (middle tertile), and by a factor 8.6 in patients with scores of 16 to 24. Additionally, each 1-m/s increase in PWV was associated with a 15% higher risk. At higher AAC (scores ≥ 5), the effect of PWV was attenuated because of a negative PWV × AAC interaction (hazard ratio [HR]: 0.895 and 0.865 for middle and upper AAC tertiles). After accounting for age, diabetes, and serum albumin, AAC and PWV remained independent predictors of outcome.
CONCLUSIONS: AAC and central arterial stiffness are independent predictors of mortality and nonfatal CV events in dialysis patients. The risk associated with an increased PWV is less pronounced at higher levels of calcification. Assessment of AAC and PWV is feasible in a clinical setting and both may be used for an accurate CV risk estimation in this heterogeneous population.

Entities:  

Mesh:

Year:  2010        PMID: 20829424      PMCID: PMC3022237          DOI: 10.2215/CJN.05120610

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  20 in total

1.  Transmedial collagen and elastin gradients in human aortas: reversal with age.

Authors:  S A Feldman; S Glagov
Journal:  Atherosclerosis       Date:  1971 May-Jun       Impact factor: 5.162

2.  Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality.

Authors:  P W Wilson; L I Kauppila; C J O'Donnell; D P Kiel; M Hannan; J M Polak; L A Cupples
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

3.  Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?

Authors:  Kennedy Cruickshank; Lisa Riste; Simon G Anderson; John S Wright; Graham Dunn; Ray G Gosling
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

4.  Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

Authors:  Joanne L Reynolds; Alexis J Joannides; Jeremy N Skepper; Rosamund McNair; Leon J Schurgers; Diane Proudfoot; Willi Jahnen-Dechent; Peter L Weissberg; Catherine M Shanahan
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

5.  New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study.

Authors:  L I Kauppila; J F Polak; L A Cupples; M T Hannan; D P Kiel; P W Wilson
Journal:  Atherosclerosis       Date:  1997-07-25       Impact factor: 5.162

6.  Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects.

Authors:  David A Goodkin; Eric W Young; Kiyoshi Kurokawa; Karl-Goran Prütz; Nathan W Levin
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

7.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

Authors:  Gérard M London; Alain P Guérin; Sylvain J Marchais; Fabien Métivier; Bruno Pannier; Hasan Adda
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

8.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Authors:  Glenn M Chertow; Steven K Burke; Paolo Raggi
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

9.  Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.

Authors:  Mitsuteru Matsuoka; Kunitoshi Iseki; Masahiro Tamashiro; Naoko Fujimoto; Nobuyoshi Higa; Takashi Touma; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2004-03       Impact factor: 2.801

10.  Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study.

Authors:  Jens Passauer; Helga Petrov; Andreas Schleser; Joachim Leicht; Klaus Pucalka
Journal:  Nephrol Dial Transplant       Date:  2009-10-06       Impact factor: 5.992

View more
  74 in total

1.  Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis.

Authors:  Fabrice Mac-Way; Véronique Couture; Mihai S Utescu; Sophie Ignace; Sacha A De Serres; Renée-Claude Loignon; Karine Marquis; Richard Larivière; Mohsen Agharazii
Journal:  Int Urol Nephrol       Date:  2013-11-17       Impact factor: 2.370

Review 2.  Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication.

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2012-04-06

3.  Reducing arterial stiffness in CKD: revising the paradigms.

Authors:  Julio A Chirinos; Raymond R Townsend
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-17       Impact factor: 8.237

4.  Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study.

Authors:  An S De Vriese; Rogier Caluwé; Lotte Pyfferoen; Dirk De Bacquer; Koen De Boeck; Joost Delanote; Didier De Surgeloose; Piet Van Hoenacker; Bruno Van Vlem; Francis Verbeke
Journal:  J Am Soc Nephrol       Date:  2019-11-08       Impact factor: 10.121

Review 5.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

Review 6.  Noninvasive imaging for assessment of calcification in chronic kidney disease.

Authors:  Cristina Karohl; Luis D'Marco Gascón; Paolo Raggi
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

7.  Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation.

Authors:  Sinee Disthabanchong; Kotcharat Vipattawat; Bunyong Phakdeekitcharoen; Chagriya Kitiyakara; Vasant Sumethkul
Journal:  Int Urol Nephrol       Date:  2017-12-13       Impact factor: 2.370

8.  MR elastography of the in vivo abdominal aorta: a feasibility study for comparing aortic stiffness between hypertensives and normotensives.

Authors:  Arunark Kolipaka; David Woodrum; Philip A Araoz; Richard L Ehman
Journal:  J Magn Reson Imaging       Date:  2011-11-01       Impact factor: 4.813

9.  Quantification of abdominal aortic aneurysm stiffness using magnetic resonance elastography and its comparison to aneurysm diameter.

Authors:  Arunark Kolipaka; Venkata Sita Priyanka Illapani; William Kenyhercz; Joshua D Dowell; Michael R Go; Jean E Starr; Patrick S Vaccaro; Richard D White
Journal:  J Vasc Surg       Date:  2016-04-27       Impact factor: 4.268

10.  Effects of lanthanum carbonate on vascular calcification in elderly maintenance hemodialysis patients.

Authors:  Xiao-Hui Wang; Xin Zhang; Chang-Jun Mu; Yong He; Qing-Ping Peng; Guo-Sheng Yang; Ming-Mei Li; Duan Liu; Jing Li; Guo-Hua Ding
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.